WHAT CAN BE LEARNED FROM THE CRISIS?
- In the near future, many VCs (venture capitalists) will become more skittish about investing in R&D-oriented drug discovery companies because they realize the high risk of this business.
- The ultimate goal for pharma and biotech companies will be to get a drug discovered faster, developed quicker, manufactured more cheaply, and marketed more widely.
- Megamergers between major pharma/biotech companies will create fewer but bigger companies.
Más...
No hay comentarios:
Publicar un comentario